Headlands Technologies LLC Celldex Therapeutics, Inc. Transaction History
Headlands Technologies LLC
- $920 Million
- Q2 2024
A detailed history of Headlands Technologies LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 9,182 shares of CLDX stock, worth $279,224. This represents 0.04% of its overall portfolio holdings.
Number of Shares
9,182
Previous 3,513
161.37%
Holding current value
$279,224
Previous $147,000
130.61%
% of portfolio
0.04%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding CLDX
# of Institutions
196Shares Held
63.5MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$246 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$143 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$114 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$103 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$101 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.42B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...